My WebLink
|
Help
|
About
|
Sign Out
Home
Agenda - Council Work Session - 04/11/2023
Ramsey
>
Public
>
Agendas
>
Council Work Session
>
2023
>
Agenda - Council Work Session - 04/11/2023
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
3/13/2025 11:12:17 AM
Creation date
4/6/2023 3:55:03 PM
Metadata
Fields
Template:
Meetings
Meeting Document Type
Agenda
Meeting Type
Council Work Session
Document Date
04/11/2023
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
566
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
HF100 NINTH ENGROSSMENT REVISOR BD 110100-9 <br />282.1 (xiii) boldione (androsta-1,4-diene-3,17-dione); <br />282.2 (xiv) calusterone (7 [beta], 17 [alpha] -dimethyl- 17 [beta] -hydroxyandrost-4-en-3 -one); <br />282.3 (xv) clostebol (4-chloro- 17 [beta] -hydroxyandrost-4-en-3 -one); <br />282.4 (xvi) dehydrochloromethyltestosterone <br />282.5 (4-chloro-17[beta]-hydroxy-17[alpha]-methylandrost-1,4-dien-3-one); <br />282.6 (xvii) desoxymethyltestosterone (17 [alpha]-methyl-5 [alpha] -androst-2-en- 17 [beta]-ol); <br />282.7 (xviii) [delta] 1-dihydrotestosterone- (17 [beta]-hydroxy-5 [alpha]-androst-l-en-3-one); <br />282.8 (xix) 4-dihydrotestosterone (17 [beta] -hydroxy-androstan-3 -one); <br />282.9 (xx) drostanolone (17 [beta] hydroxy-2 [alpha] -methyl- 5 [alpha] - andro stan- 3 -one); <br />282.10 (xxi) ethylestrenol (17 [alpha]-ethyl-17 [beta]-hydroxyestr-4-ene); <br />282.11 (xxii) fluoxymesterone <br />282.12 (9-fluoro-17[alpha]-methyl-11 [beta], 17 [beta] -dihydroxyandrost-4-en-3 -one); <br />282.13 (xxiii) formebolone <br />282.14 (2-formyl-17[alpha]-methyl-11[alpha],17[beta]-dihydroxyandrost-1,4-dien-3-one); <br />282.15 (xxiv) furazabol <br />282.16 (17 [alpha]-methyl-17 [beta]-hydroxyandrostano [2,3-c]-furazan)13 [beta]-ethyl-17 [beta] <br />282.17 -hydroxygon-4-en-3-one; <br />282.18 (xxv) 4-hydroxytestosterone (4,17 [beta] -dihydroxyandrost-4-en-3 -one); <br />282.19 (xxvi) 4-hydroxy-19-nortestosterone (4,17 [beta] -dihydroxyestr-4-en-3 -one); <br />282.20 (xxvii) mestanolone (17 [alpha]-methyl-17 [beta]-hydroxy-5 [alpha] -androstan-3 -one); <br />282.21 (xxviii) mesterolone (1 [alpha]-methyl-17 [beta]-hydroxy-5 [alpha] -androstan-3 -one); <br />282.22 (xxix) methandienone (17 [alpha]-methyl-17 [beta]-hydroxyandrost-1,4-dien-3 -one); <br />282.23 (xxx) methandriol (17 [alpha] -methyl-3 [beta], 17 [beta] -dihydroxyandrost-5 -ene); <br />282.24 (xxxi) methasterone (2 alpha-17 alpha-dimethyl-5 alpha-androstan-17beta-ol-3 -one); <br />282.25 (xxxii) methenolone (1-methyl-17 [beta] -hydroxy-5 [alpha] -androst-l-en-3 -one); <br />282.26 (xxxiii) 17 [alpha] -methyl-3 [beta], 17 [beta] -dihydroxy-5 [alpha]-androstane; <br />282.27 (xxxiv) 17 [alpha] -methyl-3 [alpha], 17 [beta] -dihydroxy-5 [alpha]-androstane; <br />282.28 (xxxv) 17 [alpha] -methyl-3 [beta], 17 [beta] -dihydroxyandrost-4-ene; <br />Article 8 Sec. 2. 282 <br />
The URL can be used to link to this page
Your browser does not support the video tag.